Alle patienterne havde fået Eprex/ Erypo, givet ved indsprøjtning i en vene, i mindst otte uger, før de enten skiftede til Epoetin Alfa Hexal eller fortsatte med Eprex/ Erypo.
All of the patients had been taking Eprex/ Erypo injected into a vein for at least eight weeks before they were either switched to Epoetin Alfa Hexal or remained on Eprex/ Erypo.